Anti-Hexokinase II antibody [3D3] (ab104836)

Publishing research using ab104836? Please let us know so that we can cite the reference in this datasheet.

ab104836 has been referenced in 4 publications.

  • Pertega-Gomes N  et al. A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy. J Pathol 236:517-30 (2015). IHC ; Human . PubMed: 25875424
  • Yao M  et al. Dicer mediating the expression of miR-143 and miR-155 regulates hexokinase II associated cellular response to hypoxia. Am J Physiol Lung Cell Mol Physiol 307:L829-37 (2014). PubMed: 25172909
  • Kim HM  et al. Site-specific metabolic phenotypes in metastatic breast cancer. J Transl Med 12:354 (2014). PubMed: 25496516
  • Chang HT  et al. Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy. Nutr Metab (Lond) 10:47 (2013). IHC . PubMed: 23829383

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"